BIO-key Expects to File Audited 2023 Results on Form 10-K and Report Q1 2024 Results and Host an Investor Call Next Week
HOLMDEL, N.J., May 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, today announced that it currently expects to file its audited 2023 results with the SEC on Form 10-K next week. BIO-key also expects to report its Q1 2024 results and hold an investor call by the end of next week. The Company will announce the timing and details of its Q1 2024 investor call once they are confirmed.
On April 23, 2024, BIO-key engaged Bush & Associates CPA as its independent registered public accounting firm.
About BIO-key International, Inc. ()
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties, including, but are not limited to, those factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022 and other filings with the Securities and Exchange Commission, that may cause actual results to differ materially from those included within or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise.
Engage with BIO-key
| Facebook – Corporate: | |
| LinkedIn – Corporate: | |
| Twitter – Corporate: | |
| Twitter – Investors: | |
| StockTwits: | |
Investor Contacts
William Jones, David Collins
Catalyst IR
or 212-924-9800
